Open AccessComparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
Author(s) -
Yeonju La,
Hye Rim Kim,
Dong Hyun Oh,
Jin Young Ahn,
Yong Chan Kim
Publication year - 2022
Publication title -
yonsei medical journal/yonsei medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.702
H-Index - 63
eISSN - 1976-2437
pISSN - 0513-5796
DOI - 10.3349/ymj.2022.63.7.611
Subject(s) - medicine , nafcillin , vancomycin , odds ratio , teicoplanin , cefazolin , staphylococcus aureus , confidence interval , glycopeptide , microbiology and biotechnology , antibiotics , biology , bacteria , genetics
This study aimed to provide compelling evidence of anti-staphylococcal beta-lactam use for methicillin-susceptible Staphylococcus aureus bloodstream infection (MSSA BSI).